Abstract Streptomyces ghanaensis ATCC14672 is the producer of phosphoglycolipid antibiotics moenomycins that for almost 40 years were used worldwide as an animal feed additive. As the use of moenomycins narrows down (due to bans in the EU and some other countries), it opens the opportunity to develop much-needed antibiotics against Gram-positive human pathogens, such as cocci. It is desirable to develop ATCC14672 strains accumulating only certain members of moenomycin family which would facilitate their purification, analysis and/or chemical modification. Here we tested sitespecific recombinases (SSRs) as a tool to manipulate the genome of ATCC14672 and to achieve aforementioned goals. We show that of three SSRs tested -Cre, Dre, and Flp -the first two efficiently catalyzed recombination reactions, while Flp showed no activity in ATCC14672 cells. Cre recombinase can be reused at least three times to modify ATCC14672 genome without detrimental effects, such as large-scale inversions or deletions. Properties of the generated strains and SSRs are discussed.
Actinomycete Streptomyces ghanaensis ATCC14672 produces a mixture of structurally related phosphoglycolipid secondary metabolites collectively known as moenomycin (or flavomycin) complex . Moenomycin was used as a feedstuff additive in many countries for decades without any significant rise of resistance in animal microflora (Pfaller 2006) . This antibiotic possesses unique mechanism of antibacterial action not shared with any other clinically useful drug (Welzel 2005; Gampe et al. 2011) ; it displays extremely high activity against many Grampositive pathogens including vancomycin-and methicillinresistant cocci; and low incidence of moenomycin resistance was reported to date Rebets et al. 2014) . For these reasons moenomycin is also considered a blueprint for new class of antibiotics much needed to counter the rise of multidrug-resistant infections.
Because moenomycin complex of ATCC14672 consists of 10-15 very similar compounds and they all are produced at low level Makitrynskyy et al. 2010) , it is challenging to use the strain as a source of a single moenomycin for biological testing and/or chemical manipulations. Nevertheless, the immense chemical complexity of the moenomycins guarantees that their fermentation-based production is the only viable route of supply. ATCC14672 genome sequence is available (Ostash et al. 2007) , which opens the door to genetic engineering of moenomycin pathway. Through judicious deletions of certain moe genes it should be possible to simplify the naturally produced moenomycin mixture down to two-three compounds of interest. However, generation of multiple mutations in ATCC14672 genome is limited by a small number of selectable markers. Excision of a marker gene after knockout and its subsequent re-use is one of the ways around this problem, and such a kind of genome engineering can be achieved with the help of site-specific recombinases (SSRs). Indeed, technology of markerless deletions is well established for many groups of organisms (Schweizer 2003) , and recently it was introduced to actinomycetes (Siegl and Luzhetskyy 2012) . Moreover, we have shown that SSR Cre efficiently promotes one round of marker eviction in S. ghanaensis (Makitrynskyy et al. 2013) . It remained unknown as to whether SSRs other than Cre can function in ATCC14672. In general, the efficiency of different SSRs varies dramatically from species to species, necessitating direct trials for a given strain (Siegl and Luzhetskyy 2012) . Also, there is no information on whether the same SSR can be used several times to perform recombination in different chromosomal loci without detrimental effects. Little information on this issue is available for any actinomycete, given that SSRs were introduced recently to this field. Here we tested three SSRs as a tool for ATCC14672 genome engineering -Flp, Cre and Dre, all of which are encoded by synthetic genes codon-optimized to match codon usage of actinomycete chromosomes (Siegl and Luzhetskyy 2012) . Actinophage C31-based plasmids carrying apramycin resistance cassette (aac(3)IV-oriT) flanked with loxP (pINT13; see Electronic supplementary materials (ESM) for full procedures and plasmid description), FRT (pINT3) or rox (pINTROX) recombination sites were transferred conjugally into ATCC14672 cells. It is known that ATCC14672 genome contains single attB C31 site (Ostash et al. 2009 ). The apramycin-resistant (Am r ) transconjugants thus contained single copy of the cassette flanked with homotypic sites for one of the three SSRs. Then SSR gene was introduced into the transconjugants on replicative plasmids, either pAL-based (moderate copy number ts-replicon of pSG5; SSR gene is driven by thiostrepton-inducible promoter tipAp) or pUWL-based (high copy number replicon of pIJ101, SSR gene is controlled by strong constitutive promoter ermEp*; see also Table S1 ). The resultant transconjugants (carrying both constructs) were selected for thiostrepton resistance. Two hundred thiostrepton resistant clones of three types (loxP+Cre, rox+Dre and FRT+ Flp) were directly checked for apramycin susceptibility (Am s ; loss of cassette because of SSR activity). The Cre and Dre expression led to immediate eviction of the cassette in 85-95 % (mean values of three independent experiments; standard deviations did not exceed 15 % of the mean) of all initial transconjugants being tested. One hundered per cent eviction of the cassette from Am r clone carrying either loxP or rox cassette was achieved after applying the marker eviction procedure described in ESM (one passage in TSB in the absence of antibiotics, plating onto oatmeal agar and resistance check via replica plating; 200 colonies were tested). In contrast, not one of the 200 tested colonies carrying pINT3+pALFLP plasmids was Am s . We passaged three independent Am r colonies under nonselective conditions, yet this did not yield Am s clones as well. It is possible that flp(a) gene is for some reason poorly expressed from thiostrepton-inducible promoter (pALFlp) in ATCC14672. We therefore tested high copy number Flp expression plasmid pUWLFlp (see above). No Am s clones were isolated in this case as well. We further speculated that inability interfere with recombination reaction. Therefore, an attempt has been made to evict FRT-flanked aac(3)IV-oriT cassette from S. ghanaensis dH5 genome. In dH5 strain the cassette is located within moe cluster 2, in place of amidotransferase gene moeH5 . However, in spite of repeated attempts we failed to isolate even one colony exhibiting Am s phenotype. We scaled up the experiment and screened 2000 pINT3 + clones for marker loss, yet not one Am s clone was found. The obtained results imply that efficiency of Flp-mediated marker excision is below 0.05 % (less than one clone out of 2000 tested). This is in contrast to literature data (Fedoryshyn et al. 2008) , where efficiency of Flp was within 10-40 % range. Finally, we showed via semiquantitative RT-PCR analysis that flp(a) gene is transcribed relatively well from pALFLP and pUWLFLP constructs, the latter giving more transcript (ESM Fig. S1 ). Hence, failure to detect Flp recombinase activity is not related to poor or absent gene transcritption. somal state, most likely because of excision of tandemly duplicated copies of the plasmid (Ostash et al. 2009 ). We took advantage of this fact to retrieve and sequence pINT3, pINT13 and pINTROX derivatives from S. ghanaensis after expression of SSRs. For this purpose E. coli DH5α was transformed to ampicillin resistance (marker gene in the vector scaffold of the aforementioned plasmids) with total DNA isolated from the transconjugants. Indeed, in all three cases we were able to obtain ampicillin-resistant E. coli clones carrying expected plasmids. Sequencing of pINT13 and pINTROX derivatives revealed scar sequences instead of aac(3)IV-oriT cassette, while pINT3 remained intact.
Next we focused on Cre recombinase and set out to study its potential for multiple rounds of marker eviction. S. ghanaensis ΔabsB, carrying scar sequence in place of absBgh gene (SSFG_02129, see Fig. 1 ) after Cre-mediated marker eviction (Makitrynskyy et al. 2013) , has been chosen as a host to generate unmarked moeH5 deletion. Helper plasmid pALCre was introduced into moeH5 knockout strain B38 (see ESM methods and Fig. S1 ), and Am s clones were readily isolated from the primary transconjugants (out of 200 clones checked 80 % displayed the desired phenotype). One clone, to excise FRT-flanked apramycin cassette can be caused by its position, namely attB φC31 site or its surroundings somehow It was shown by us previously that in ATCC14672 cell φC31-based integrative plasmids can exist in extrachromo-φ φ labelled as B38.3 (Fig. S2 ), was chosen for further studies. PCR analysis confirmed marker eviction from B38.3 (Fig. S3) . Also, mass-spectrometry analysis showed that B38.3 produced expected phosphoglycolipid compound, nosokomycin A (ESM, Fig. S4 ). We detected no clones with impaired growth and/or sporulation upon pALCre expression in B38 strain, which would be indicative of large-scale inversion between loxP sites at absB and moe cluster loci (Fig. 1) . Although our experimental procedures cannot completely rule the inversions, we think this kind of genome rearrangement is rare, since the frequency of Am s clones in this experiment was at the level observed in model (pINT13-based) studies.
Next we decided to generate markerless deletion of moeGT3moeR5moeS5 genes in B38.3 genome (already containing two loxP scars) using Cre-loxP system. First we generated strain B38.3/8 (as described in ESM) carrying loxPflanked aac(3)IV-oriT cassette in place of moeGT3-S5 ( Fig. 1 and S2 ). Here loxP scar in place of moeH5 is located 11 kb away from loxP sites flanking the cassette. Also, the latter were in orientation opposite to the loxP-scar in place of moeH5. Upon expression of Cre recombinase in B38.3/8 we observed 20 % of Am s clones. It is likely that Cre is as efficient in B38.3/8 as it was in B38, but in the former case part of recombinase activity resulted in rearrangements that are lethal (large deletions) or did not lead to marker loss (such as inversions). PCR analysis of one clone, labelled as B38.3/80, confirmed marker eviction from moeGT3-R5-S5 knockout site (Fig. S2, S3 ). Among 100 tested Am s clones we found one that did not produce moenomycin A. Analysis of this clone, referred to as B38.3/21, revealed the inversion of moe cluster segment between two loxP-scars in the cluster (Fig. S2, S5 ). We wondered as to whether the loss of moenomycin production by B38.3/21 is indeed a consequence of inversion, or it is a result of the other, unanticipated mutations/rearrangements in genome of this strain. To address this issue, Cre-expressing construct pALCre was re-introduced into B38.3/21 cells, and the resultant transconjugants were checked for moenomycin production. The rationale behind this experiment was as follows. Expression of Cre SSR in B38.3/21 cells would lead (presumably, at low frequency) to restoration of initial order of moe genes within the cluster and moenomycin biosynthesis, provided that inversion was the sole reason for blocked antibiotic production. Indeed, of the 150 clones checked, three produced moenomycin at the level of initial (B38.3) strain, lending support for the above mentioned suggestion.
In conclusion, we show here that SSR Dre and Cre are efficient tools for manipulation of ATCC14672 genome. The latter can be reused several times to generate markerless deletions of distantly located genome loci. As a proof of principle, unmarked deletion of amidotransferase gene moeH5 has been generated, yielding the strain B38.3 with moenomycin production pattern narrowed down to nosokomycin A. We also show that, at low frequency, Cre recombinase can cause additional rearrangements between proximal loxP scars, such as inversion in case of B38.3/21 clone. Although undesired from the moenomycin production engineering point of view, the latter result demonstrates the significance of moe gene order for their expression and/or regulation, and subsequent moenomycin production. Fig. 1 Manipulating ATCC14672 genome with SSRs. a. Genomic loci of ATCC14672 that were subject to manipulations with SSRs (shaded in grey). Approximate distances from the Bleft^end of the chromosome and between moeH5 and moeGT3 genes are indicated. The distances were obtained from available whole-genome sequencing data for ATCC14672 genome (available at www.broadinstitute.org). Only relevant moe genes are shown. Cosmids moeno38 and moeno40 carrying overlapping fragment of moe cluster are shown at the bottom. b. Schematic representation of relative localization of loxP sites (black triangles) in genomes of the strains mentioned in the text. Double slash line on the schematic represents distant location (approx. 600 kb) of loxP scar in place of absB gene relative to moe genes. More details are given in ESM Fig. S1 , S2, S4. Abbreviations: M -marker gene; H5, KO, GRS -genes moeH5, moeK5-moeX5 segment, moeGT3moeR5moeS5, respectively
